Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader ...

Zenas BioPharma, Inc.’s ZBIO share price has surged by 13.37%, which has investors questioning if this is right time to sell.

A live webcast and archived replay of the Company's presentation can be accessed under "Events and Presentations" in the Investor & Media Relations section of the Zenas BioPharma website. About Zenas ...

Zenas Biopharma Inc stock price live, this page displays NASDAQ ZBIO stock exchange data. View the ZBIO premarket stock price ahead of the market session or assess the after hours quote.

The funds will support the development of Ascentage’s pipeline, including its lead candidate olverembatinib to treat blood ...

LPL Solar LLC is pleased to announce the promotion of David Ciampini to Vice President of Project Development. David brings ...

Just a few months after raising $200 million in third-round financing, immunology specialist Zenas BioPharma has filed an initial public offering in the US seeking to add another $100 million to ...

Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...

The filing comes shortly after Zenas BioPharma and Bicara Therapeutics also threw their hat into the IPO ring, and just a few days after MBX raised $63.5 million in a Series C led by Deep Track ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

MCLEAN, Va., Jan. 28, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that its Mission Technologies division was ...

We recently published a list of Top 10 Trending AI Stocks on Latest News. In this article, we are going to take a look at where ZenaTech, Inc. (NASDAQ:ZENA) stands against other top trending AI stocks ...